Alvotech Q4 2025 and Full Year 2025 Financial Results
Alvotech (ALVO)
Company Research
Source: GlobeNewswire
REYKJAVIK, Iceland, March 18, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ US: ALVO, ICELAND: ALVO, STOCKHOLM: ALVO SDB) Financial Highlights A supplemental long-form earnings release providing additional operational details and business update for Q4 2025 and the full year is available at: https://investors.alvotech.com/earnings-calendar The supplemental document is provided solely for reference and is not part of this SEC Form 6-K. The Form 6-K should not be read together with, or construed as referring to, the supplemental long-form release. Q4 2025 Highlights Total revenues1 were $173 million, up 13% Year-on-Year (YoY)Adjusted EBITDA1 was $69 million with Gross Margin at 66%AVT05 was approved as a biosimilar to Simponi® in the UK and European Economic Area (EEA)AVT03 was approved as a biosimilar to Prolia® and Xgeva® in the EEAThe EMA accepted for review a marketing application for AVT23, referencing Xolair®After the end of the quarter, Alvotech entered into supply and comm
Show less
Read more
Impact Snapshot
Event Time:
ALVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALVO alerts
High impacting Alvotech news events
Weekly update
A roundup of the hottest topics
ALVO
News
- Alvotech (ALVO) had its price target lowered by UBS Group AG from $10.00 to $6.00. They now have a "buy" rating on the stock.MarketBeat
- Alvotech (ALVO) had its price target lowered by Barclays PLC from $5.00 to $4.00. They now have an "underweight" rating on the stock.MarketBeat
- Alvotech (ALVO) was upgraded by Zacks Research from "strong sell" to "hold".MarketBeat
- Did Alvotech's (ALVO) Profitability Turn and Expanding Biosimilar Pipeline Just Recast Its Investment Narrative? [Yahoo! Finance]Yahoo! Finance
- Alvotech (ALVO) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
ALVO
Earnings
- 11/12/25 - Beat
ALVO
Sec Filings
- 3/19/26 - Form 6-K
- 3/12/26 - Form SCHEDULE
- 2/27/26 - Form 6-K
- ALVO's page on the SEC website